The pathophysiology of aortic dilatation in Marfan syndrome (MFS) is a complicated process. Fibrillin-1 is a regulator of TGF-beta bioavailability, which in turnÂ leads to inflammation, fibrosis, and activation of specific matrix metalloproteinases (MMPs), particularly MMP-2 and MMP-9.